Stockscreener 앱 받기
20.13
4.19%
-0.883
시간 외 거래:
20.10
-0.027
-0.13%
전일 마감가:
$21.01
열려 있는:
$20.11
하루 거래량:
5,963
Relative Volume:
1.44
시가총액:
$1.88B
수익:
$80.00M
순이익/손실:
$-172.98M
주가수익비율:
-10.36
EPS:
-1.9419
순현금흐름:
$-178.54M
1주 성능:
+6.00%
1개월 성능:
-15.95%
6개월 성능:
-37.33%
1년 성능:
-23.98%
1일 변동 폭
$20.11
$20.70
1주일 범위
$19.29
$22.58
52주 변동 폭
$18.56
$48.45
Ascentage Pharma Group International Adr Stock (AAPG) Company Profile
Compare AAPG vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AAPG
Ascentage Pharma Group International Adr
|
20.13 | 1.96B | 80.00M | -172.98M | -178.54M | -1.9419 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Ascentage Pharma Group International Adr Stock (AAPG) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-24 | 개시 | Deutsche Bank | Buy |
| 2026-03-12 | 재개 | BTIG Research | Buy |
| 2026-01-13 | 개시 | Rodman & Renshaw | Buy |
| 2025-12-04 | 개시 | Oppenheimer | Outperform |
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-11-10 | 개시 | BTIG Research | Buy |
| 2025-11-05 | 개시 | Piper Sandler | Overweight |
| 2025-03-27 | 개시 | JP Morgan | Overweight |
모두보기
Ascentage Pharma Group International Adr 주식(AAPG)의 최신 뉴스
AAPG Stock Price, Quote & Chart | ASCENTAGE PHARMA GR-ADR (NASDAQ:AAPG) - ChartMill
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), BeOne Medicines (ONC) and Nektar Therapeutics (NKTR) - The Globe and Mail
Ascentage Pharma: Buy Rating Reiterated on Advancing CML/ALL Pipeline and DCF-Supported Unchanged $48 Price Target - TipRanks
Analysts Are Bullish on These Healthcare Stocks: SI-Bone (SIBN), Perspective Therapeutics (CATX) - The Globe and Mail
Ascentage Pharma to Present 17 Hematology Clinical Updates at June 2026 EHA Congress - TipRanks
Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Liquidia Technologies (LQDA) and Bicara Therapeutics Inc. (BCAX) - The Globe and Mail
Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association Congress - ChartMill
Ascentage Pharma to Highlight Oncology Portfolio at May–June 2026 Investor Conferences - TipRanks
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Regeneron (REGN) and Collegium Pharmaceutical (COLL) - The Globe and Mail
AAPG: Ascentage Pharma Group InternationalUnsponsored ADRInteractive Chart - Zacks Investment Research
Analysts Are Bullish on Top Healthcare Stocks: CG Oncology, Inc. (CGON), Evolus (EOLS) - The Globe and Mail
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap DownTime to Sell? - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Opus Genetics (IRD), NeoGenomics (NEO) and Teladoc (TDOC) - The Globe and Mail
Ascentage Pharma Group InternationalUnsponsored ADR (NASDAQ:AAPG) Short Interest Down 51.1% in April - MarketBeat
Analysts’ Top Healthcare Picks: AbbVie (ABBV), Regeneron (REGN) - The Globe and Mail
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume IncreaseHere's Why - MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Down 8.4%What's Next? - MarketBeat
Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026 - GlobeNewswire Inc.
Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (MNPR) and Agios Pharma (AGIO) - The Globe and Mail
Ascentage (AAPG) Stock: Support and Resistance (Momentum Fading) 2026-04-16Momentum Investing - Xã Thanh Hà
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap UpShould You Buy? - MarketBeat
Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Sahm
Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Nuvation Bio (NUVB) - The Globe and Mail
Ascentage Pharma Group International (NASDAQ:AAPG) Upgraded at China Intl Cap - Defense World
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Up 12%Should You Buy? - MarketBeat
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Sahm
Truist Financial Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG) - The Globe and Mail
BTIG Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG) - The Globe and Mail
Earnings Scheduled For March 25, 2026 - Sahm
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Up 20.3%Should You Buy? - marketbeat.com
Short Interest in Ascentage Pharma Group InternationalUnsponsored ADR (NASDAQ:AAPG) Increases By 546.9% - MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Stock Price Down 7.7%Here's Why - MarketBeat
Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026 - Sahm
Ascentage Pharma Sets March 25 Board Meeting on 2025 Results and Potential Final Dividend - TipRanks
Ascentage Pharma Sets March 25, 2026 Date to Unveil 2025 Unaudited Results and Business Update - The Globe and Mail
Ascentage Pharma Group International Adr (AAPG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Ascentage Pharma Group International Adr 주식 (AAPG) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Zhai Yifan | Chief Medical Officer |
May 21 '26 |
Option Exercise |
0.00 |
92,746 |
0 |
405,280 |
| Yang Dajun | Chairman and CEO |
May 21 '26 |
Option Exercise |
0.00 |
92,746 |
0 |
405,280 |
| Yang Dajun | Chairman and CEO |
May 21 '26 |
Option Exercise |
0.00 |
95,575 |
0 |
1,193,569 |
1.49%
0.12%
자본화:
|
볼륨(24시간):